Focal microinjection of γ-acetylenic GABA into the rat entorhinal cortex: Behavioral and electroencephalographic abnormalities and preferential neuron loss in layer III

Experimental Neurology

Volumn 153, Issue 2, 1998, Pages 203-213

  Wu, Hui Qiu ^a   Schwarcz, Robert ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Dizolcipine (MK 801); Epilepsy; Epileptogenesis; Excitotoxicity; GABA; Neuroprotection; NMDA

Indexed keywords

4 AMINO 5 HEXYNOIC ACID; DIZOCILPINE;

ANIMAL CELL; ARTICLE; CELL LOSS; ELECTROENCEPHALOGRAPHY; ENERGY METABOLISM; ENTORHINAL CORTEX; EPILEPTOGENESIS; IMAGE ANALYSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; TEMPORAL LOBE EPILEPSY; TISSUE SECTION; TRANSAMINATION;

EID: 0032191186     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6908     Document Type: Article

References (51)

1. Arnold S. E., Hyman B. T., Van Hoesen G. W., Damasio A. R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiat. 48:1991;625-632.
2. Beal M. F., Brouillet E., Jenkins B. G., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R., Hyman B. T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
3. Beal M. F., Swartz K. J., Hyman B. T., Storey E., Finn S. F., Koroshetz W. Amino-oxyacetic acid results in excitotoxic lesions by a novel indirect mechanism. J. Neurochem. 57:1991;1068-1073.
4. Bear J., Fountain N. B., Lothman E. W. Responses of the superficial entorhinal cortexin vitro. J. Neurophysiol. 76:1996;2928-2940.
5. Brouillet E., Henshaw D. R., Schulz J. B., Beal M. F. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10. Neurosci. Lett. 177:1994;58-62.
6. Denslow M. J., Lothman E. W., Eid T., Du F., Schwarcz R. Hyperexcitability in area CA1 after selective lesions of layer III entorhinal cortex. Soc. Neurosci. Abstr. 21:1995;181.16.
7. Dickson C. T., Mena A. R., Alonso A. Electroresponsiveness of medial entorhinal cortex layer III neuronsin vitro. Neuroscience. 81:1997;937-950.
8. Du F., Eid T., Lothman E. W., Köhler C., Schwarcz R. Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy. J. Neurosci. 15:1995;6301-6313.
9. Du F., Eid T., Schwarcz R. Neuronal damage after the injection of aminooxyacetic acid into the rat entorhinal cortex: A silver impregnation study. Neuroscience. 82:1998;1165-1178.
10. Du F., Schwarcz R. Aminooxyacetic acid causes selective neuronal loss in layer III of the rat medial entorhinal cortex. Neurosci. Lett. 147:1992;185-188.
11. Du F., Whetsell W. O. Jr., Abou-Khalil B., Blumenkopf B., Lothman E. W., Schwarcz R. Preferential neuronal loss of layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epil. Res. 16:1993;223-233.
12. Du F., Williamson J., Bertram E., Lothman E., Okuno E., Schwarcz R. Kynurenine pathway enzymes in a rat model of chronic epilepsy: Immunohistochemical study of activated glial cells. Neuroscience. 55:1993;975-988.
13. Eid T., Du F., Schwarcz R. Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region. Neuroscience. 68:1995;645-656.
14. Empson R. M., Heinemann U. The perforant path projection to hippocampal area CA1 in the rat hippocampal-entorhinal cortex combined slice. J. Physiol. 484:1995;707-720.
15. Foster A. C., Vezzani A., French E. D., Schwarcz R. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48:1984;273-278.
16. Gastaut H. Colloque sur les problèmes d'anatomie normale et pathologique posés par les décharges épileptiques. Acta Med. Belg. 1956;5-66.
17. Gloveli T., Schmitz D., Heinemann U. Prolonged inhibitory potentials in layer III projection cells of the rat medial entorhinal cortex induced by synaptic stimulation in vitro. Neuroscience. 80:1997;119-131.
18. Greene J. G., Porter R. H. P., Eller R. V., Greenamyre J. T. Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61:1993;1151-1154.
19. Hudson L. P., Monoz D. G., Miller L., McLachlan R. S., Girvin J. P., Blume W. T. Amygdaloid sclerosis in temporal lobe epilepsy. Ann. Neurol. 33:1993;622-631.
20. Insausti R., Herrero M. T., Witter M. P. Entorhinal cortex of the rat: Cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus. 7:1997;146-183.
21. Johansen F. F., Diemer N. H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol. Scand. 84:1991;1-6.
22. Jung M. J., Lippert B., Metcalf B. W., Schechter P. J., Böhlen P., Sjoerdsma A. The effect of 4-amino-hex-5-ynoic acid (γ-acetylenic GABA), a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. J. Neurochem. 28:1977;717-723.
23. Kälviäinen R., Salmenperä T., Partanen K., Vainio P., Riekkinen P., Pitkänen A. MRI volumetry and T2 relaxometry of the amygdala in newly diagnosed and chronic temporal lobe epilepsy. Epil. Res. 28:1997;39-50.
24. Kessler M., Terramani T., Lynch G., Baudry M. A glycine site associated with N-methyl-D-aspartic acid receptors: Characteristics and identification of a new class of antagonists. J. Neurochem. 52:1989;1319-1328.
25. Brain Res. Bull. 5:1980;1-946.
26. Levisohn L. F., Isacson O. Excitotoxic lesions of the rat entorhinal cortex. Effects of selective neuronal damage on acquisition and retention of a non-spatial reference memory task. Brain Res. 564:1991;230-244.
27. Löscher W. Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA. J. Neurochem. 34:1980;1603-1608.
28. Margerison J. H., Corsellis J. A. N. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain. 89:1966;499-530.
29. McMaster O. G., Baran H., Wu H.-Q., Du F., French E. D., Schwarcz R. γ-Acetylenic GABA produces axon-sparing neurodegeneration after focal injection into the rat hippocampus. Exp. Neurol. 124:1993;184-191.
30. McMaster O. G., Du F., French E. D., Schwarcz R. Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: Evidence for mediation by NMDA receptors. Exp. Neurol. 113:1991;367-374.
31. Metcalf B. Inhibitors of GABA metabolism. Biochem. Pharmacol. 28:1979;1705-1712.
32. Olney J. W., Collins R. C., Sloviter R. S. Excitotoxic mechanisms of epileptic brain damage. Delgado-Escueta A. V., Ward A. A. Jr., Woodbury D. M., Porter R. J. Advances in Neurology. 1986;857-877 Raven Press, New York.
33. Palfreyman M. G., Schechter P. J., Buckett W. R., Tell G. P., Koch-Weser J. The pharmacology of GABA-transaminase inhibitors. Biochem. Pharmacol. 30:1981;817-824.
34. Rempe D. A., Mangan P. S., Lothman E. W. Regional heterogeneity of pathophysiological alterations in CA1 and dentate gyrus in a chronic model of temporal lobe epilepsy. J. Neurophysiol. 74:1995;816-828.
35. Scharfman H. E. Hyperexcitability of entorhinal cortex and hippocampus after application of aminooxyacetic acid (AOAA) to layer III of the rat medial entorhinal cortex in vitro. J. Neurophysiol. 76:1996;2986-3001.
36. Scharfman H. E., Goodman J. H., Du F., Schwarcz R. Chronic epileptiform activity in the entorhinal cortex after injection of the excitotoxin aminooxyacetic acid (AOAA) into the entorhinal cortex in vivo. Epilepsia. 38:1997;123.
37. Schwartzkroin P. A. Cellular physiology of human epilepsy. Epil. Res. 17:1994;185-192.
38. Sloviter R. S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: The "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus. 1:1991;41-66.
39. Speciale C., Wu H.-Q., Gramsbergen J. B. P., Turski W. A., Ungerstedt U., Schwarcz R. Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: Effect of aminooxyacetic acid. Neurosci. Lett. 116:1990;198-203.
40. Steward O., Scoville S. A. Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat. J. Comp. Neurol. 169:1976;347-370.
41. Stone T. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45:1993;309-379.
42. Tell G., Böhlen P., Schechter P. J., Koch-Weser J., Agid Y., Bonnet A. M., Coquillat G., Chazot G., Fischer C. Treatment of Huntington disease with γ-acetylenic GABA, an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Neurology. 31:1981;207-211.
43. Turski L., Ikonomidou C., Turski W. A., Bortolotto Z. A., Cavalheiro E. A. Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy. Synapse. 3:1989;154-171.
44. Turski W. A., Gramsbergen J. B. P., Traitler H., Schwarcz R. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J. Neurochem. 52:1989;1629-1636.
45. Ueki A., Miwa C., Oohara K., Miyoshi K. Histological evidence for cholinergic alteration in the hippocampus following entorhinal cortex lesion. J. Neurol. Sci. 142:1996;7-11.
46. Urbanska E., Ikonomidou C., Sieklucka M., Turski W. A. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum. Synapse. 9:1991;129-135.
47. Van Hoesen G. W., Hyman B. T., Damasio A. R. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus. 1:1991;1-8.
48. Wallach D. P. Studies on the GABA pathway. I. The inhibition of γ-aminobutyric acid-α-ketoglutaric acid transaminasein vitroin vivo. Biochem. Pharmacol. 5:1961;323-344.
49. Witter M. P. Organization of the entorhinal-hippocampal system: A review of current anatomical data. Hippocampus. 3:1993;33-44.
50. Wu H.-Q., Baran H., Ungerstedt U., Schwarcz R. Kynurenic acid in the quinolinate-lesioned rat hippocampus: Studiesin vitroin vivo. Eur. J. Neurosci. 4:1992;1264-1270.
51. Zeevalk G. D., Nicklas W. J. Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253:1990;1285-1292.